TSE:HLS HLS Therapeutics (HLS) Stock Price, News & Analysis C$3.26 -0.08 (-2.40%) (As of 09/13/2024 05:18 PM ET) Add Compare Share Share Today's RangeC$3.24▼C$3.2650-Day RangeC$3.01▼C$3.6452-Week RangeC$3.00▼C$5.48Volume2,967 shsAverage Volume25,554 shsMarket CapitalizationC$103.64 millionP/E RatioN/ADividend Yield6.13%Price TargetC$3.63 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsHeadlinesInsider TradesStock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsHeadlinesInsider Trades Get HLS Therapeutics alerts: Email Address Ad Porter & CompanyWar on Elon Escalates… Elon Musk just built a supercomputer in Memphis, Tennessee. It took him only 122 days. Dubbed “Colossus,” this supercomputer aims to become the most powerful AI training system in the world. Housed in a 785,000 sq. ft facility in Memphis, Colossus will soon require 150 megawatts of electricity per day. That’s about equal to the amount of energy needed to power 100,000 homes per year. Click here and take notes. About HLS Therapeutics Stock (TSE:HLS)HLS Therapeutics Inc., a specialty pharmaceutical company, acquires and commercializes pharmaceutical products in the specialty central nervous system and cardiovascular markets in Canada, the United States, and internationally. The company's product portfolio includes Clozaril, an atypical antipsychotic for management of symptoms of treatment-resistant schizophrenia; and Vascepa, an icosapent ethyl capsules for cardiovascular disease. It also distributes MyCare psychiatry lab assays; and MyCare Insite, a point-of-care device to measure patient drug levels. In addition, the company holds the Canadian rights of Trinomia, a cardiovascular therapeutic; and a portfolio of royalty interests of four healthcare products. HLS Therapeutics Inc. is headquartered in Etobicoke, Canada.Read More HLS Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart HLS Stock News HeadlinesAugust 28, 2024 | finance.yahoo.comHLS Therapeutics to Present at H.C. Wainwright's 26th Annual Global Investment ConferenceAugust 23, 2024 | finance.yahoo.comHLS Therapeutics Inc. (74D.F)September 14, 2024 | Porter & Company (Ad)War on Elon Escalates… Elon Musk just built a supercomputer in Memphis, Tennessee. It took him only 122 days. Dubbed “Colossus,” this supercomputer aims to become the most powerful AI training system in the world. Housed in a 785,000 sq. ft facility in Memphis, Colossus will soon require 150 megawatts of electricity per day. That’s about equal to the amount of energy needed to power 100,000 homes per year. August 13, 2024 | msn.comFDA gives thumbs down to MDMA for now, demanding further researchAugust 8, 2024 | finance.yahoo.comHLS Therapeutics Announces Q2 2024 Financial ResultsAugust 1, 2024 | msn.comAmarin Corporation plc (NASDAQ:AMRN) Q2 2024 Earnings Call TranscriptJuly 31, 2024 | msn.comAmarin Plc (AMRN) Q2 2024 Earnings Call TranscriptJuly 29, 2024 | finance.yahoo.comHLS Announces Reimbursement for Vascepa® under Alberta's Provincial Drug PlanSeptember 14, 2024 | Porter & Company (Ad)War on Elon Escalates… Elon Musk just built a supercomputer in Memphis, Tennessee. It took him only 122 days. Dubbed “Colossus,” this supercomputer aims to become the most powerful AI training system in the world. Housed in a 785,000 sq. ft facility in Memphis, Colossus will soon require 150 megawatts of electricity per day. That’s about equal to the amount of energy needed to power 100,000 homes per year. July 25, 2024 | sg.finance.yahoo.comFTSE 100 LIVE: European stocks slump after Wall Street suffers worst sell-off in over a yearJuly 25, 2024 | ca.finance.yahoo.comHLS Therapeutics to Host Q2 Fiscal 2024 Financial Results Conference CallJuly 19, 2024 | theglobeandmail.comClosing Bell: Hls Therapeutics Inc flat on Wednesday (HLS)May 28, 2024 | finance.yahoo.comNew Study Published on the Impact of Pharmaceutical Support Programs on Persistence with Clozapine TreatmentMay 9, 2024 | morningstar.comHLS Therapeutics Inc HLSMay 9, 2024 | finance.yahoo.comHLS Therapeutics Announces Q1 2024 Financial ResultsApril 9, 2024 | finance.yahoo.comHLS Therapeutics to Present at the 2024 Bloom Burton & Co. Healthcare Investor ConferenceApril 8, 2024 | finance.yahoo.comNew REDUCE-IT® Analyses Show VASCEPA® (Icosapent Ethyl) Benefit in High-Risk Cardiovascular Disease Patient SubgroupsMarch 17, 2024 | finance.yahoo.comEarnings Release: Here's Why Analysts Cut Their HLS Therapeutics Inc. (TSE:HLS) Price Target To CA$6.57See More Headlines Receive HLS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for HLS Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings8/08/2024Today9/13/2024Next Earnings (Estimated)11/14/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeTSE SectorMedical Industry Drug Manufacturers - Specialty & Generic Sub-IndustryN/A Current SymbolTSE:HLS CUSIPN/A CIKN/A Webwww.hlstherapeutics.com Phone647-495-9000FaxN/AEmployees91Year FoundedN/APrice Target and Rating Average Stock Price TargetC$3.63 High Stock Price TargetC$4.00 Low Stock Price TargetC$3.25 Potential Upside/Downside+11.2%Consensus RatingHold Rating Score (0-4)2.33 Research Coverage3 Analysts Profitability EPS (Most Recent Fiscal Year)C($1.02) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeC$-24,090,000.00 Net Margins-40.90% Pretax MarginN/A Return on Equity-24.82% Return on Assets-2.89% Debt Debt-to-Equity Ratio100.44 Current Ratio2.02 Quick Ratio1.01 Sales & Book Value Annual SalesC$58.89 million Price / Sales1.76 Cash FlowC$0.21 per share Price / Cash Flow15.22 Book ValueC$2.60 per share Price / Book1.25Miscellaneous Outstanding Shares31,790,000Free FloatN/AMarket CapC$103.64 million OptionableNot Optionable Beta1.04 7 AI Stocks to Invest In: An Introduction to AI Investing For Self-Directed InvestorsAs the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.Get This Free Report Key ExecutivesDr. Jason A. Gross Pharm.D. (Age 59)Vice President of Scientific Affairs Comp: $357.86kMr. Ryan C. Lennox B.A. (Age 43)J.D., Senior VP of Legal, HR & Compliance and Corporate Secretary Comp: $393.31kMr. Craig Stuart Millian M.B.A. (Age 56)CEO & Director Mr. John Hanna CPACGA, M.B.A., Interim CFO & Non-Independent DirectorBrian T. WalshSenior Vice President of CommercialMr. David Spence (Age 56)VP & Corporate Controller More ExecutivesKey CompetitorsAurora CannabisTSE:ACBSupreme CannabisTSE:FIREOrganigramTSE:OGIESSA PharmaCVE:EPIICC LabsCVE:ICCView All CompetitorsInsidersJohn Gordon HannaBought 1,200 shares on 8/14/2024Total: C$3,828.00 ($3.19/share)Craig MillianBought 2,500 shares on 5/15/2024Total: C$7,250.00 ($2.90/share)Craig MillianBought 5,000 shares on 11/16/2023Total: C$13,000.00 ($2.60/share)Brian Thomas WalshBought 1,000 shares on 11/15/2023Total: C$2,910.00 ($2.91/share)Polar Asset Management Partners Inc.Bought 20,000 shares on 11/10/2023Total: C$86,000.00 ($4.30/share)View All Insider Transactions HLS Stock Analysis - Frequently Asked Questions How have HLS shares performed this year? HLS Therapeutics' stock was trading at C$3.95 at the start of the year. Since then, HLS stock has decreased by 17.5% and is now trading at C$3.26. View the best growth stocks for 2024 here. How were HLS Therapeutics' earnings last quarter? HLS Therapeutics Inc. (TSE:HLS) released its earnings results on Thursday, August, 8th. The company reported ($0.25) earnings per share for the quarter, hitting the consensus estimate of ($0.25). The company had revenue of $19.87 million for the quarter, compared to analyst estimates of $19.25 million. HLS Therapeutics had a negative trailing twelve-month return on equity of 24.82% and a negative net margin of 40.90%. How do I buy shares of HLS Therapeutics? Shares of HLS stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.Compare Top Brokerages Here. What other stocks do shareholders of HLS Therapeutics own? Based on aggregate information from My MarketBeat watchlists, some other companies that HLS Therapeutics investors own include Cargojet (CJT), Fairfax Financial (FFH), Fortis (FTS), Aurora Cannabis (ACB), Aphria (APHA), Alimentation Couche-Tard (ATD.B) and BlackBerry (BB). This page (TSE:HLS) was last updated on 9/14/2024 by MarketBeat.com Staff From Our PartnersThe death of Nvidia?Today, I’m warning of another looming catastrophe. Only this time, it’s not in pot stocks, cryptos, or U.S....Porter & Company | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | Sponsored44-year Wall Street Vet: “Permanent devastation is coming to America”After 44 years on Wall Street, I've seen it all... Black Monday, the Great Recession, the Covid crash. B...InvestorPlace | SponsoredNvidia is Pivoting to Solve Big Tech’s $1 Trillion ProblemTaiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as ...Weiss Ratings | SponsoredInvest before this deal closes on 9/18This company can create aviation fuels from waste, they qualify to help airlines meet net-zero carbon pledges ...Deal Maker | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredUnlock the Secret to Easy Wins with Iron CondorsDiscover the power of Iron Condor trades – a low-risk, high-reward strategy that allows you to profit consiste...Netpicks | SponsoredPlace this $0.99 trade BEFORE the electionEarlier this year, Millionaire Trader Nate Bear of Monument Traders Alliance went live in front of thousands o...Monument Traders Alliance | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding HLS Therapeutics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share HLS Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
